Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies.
2020
Current combination therapies elicit high response rates in B cell malignancies, often using CD20 antibodies as the backbone of therapy. However, many patients eventually relapse or develop progres...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
31
References
2
Citations
NaN
KQI